MLYS Shareholders Elect Class III Directors, Ratify EY as Auditor
Mineralys Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $31.50
+5.7% in 3d after detection
Post-detection moves
1h
—
1d
+0.5%
3d
+5.7%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS